ArticleActa pharmaceutica Sinica. B2026

Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy.

Hong Toan Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.